Let’s face it: pharmaceutical construction isn’t your average building site. You’re not just dealing with concrete and steel; you’re dealing with regulatory scrutiny, sterile environments, and equipment that costs more than most houses. And in Denmark’s growing life sciences sector, the pressure to get it right, first time, on time, is only increasing. Yet the industry seems to be struggling with this delivery. Why is that? That is the topic of this episode.

We've invited Steffen Hebsgaard Muff, an experienced construction lawyer, to help us unravel these challenges, and help us to change things for the better going forward.

What you'll learn from today's episode of Inventing Construction:

- Where major construction projects go wrong
- Why risk allocation doesn't work
- Where investors misunderstand construction
- How to build smarter: Lessons learned

You can also listen to Inventing Construction on these platforms:
Spotify: https://open.spotify.com/show/2aAxc0iqOe2JJly3jCh9jV?si=8db208888a9a4e4c
Apple podcast: https://podcasts.apple.com/us/podcast/inventing-construction/id1629403210
YouTube: https://www.youtube.com/playlist?list=PLmFqJlVzEa6Lc_7LOTjvac2oTbRRk9HdK

We would love for you to continue the conversation with us on LinkedIn:
Ross: https://www.linkedin.com/in/ross-griffin-kosmos/
Elia: https://www.linkedin.com/in/eliaarquitectatecnica/
Steffen:https://www.linkedin.com/in/steffen-hebsgaard-m%C3%B8ller-38671540/
KOSMOS: https://www.linkedin.com/company/kosmos-dk

Thanks for listening!